A scoping review examined ways to reduce harms among people who may not be seeking immediate benzodiazepine cessation.
Thirty-five studies were grouped into direct interventions, policy approaches, and population-specific responses. Drug checking was the most frequently reported direct approach. Prescribing and policy interventions showed mixed effects, including possible unintended consequences. The authors identified gaps for people not engaged in treatment.
A scoping review maps heterogeneous evidence rather than proving a single intervention’s effect size. Positive reports do not establish uniform effectiveness, and changes in prescribing policy can shift where or how substances are obtained. More robust evaluation was explicitly needed.
For an expert or policy discussion, distinguish reduced prescribing, reduced exposure, and reduced harm. Those outcomes need not move together. The paper supports evaluating access, unregulated supply, detection methods, and patient goals without claiming that every intervention has demonstrated overdose prevention.
Source reviewed: Harm reduction approaches for the use of benzodiazepines a scoping review (PMC12502574). This article summarizes the supplied paper; forensic applications above are interpretive analysis.
Related reading: Professionals’ Benzodiazepine Goals Included Harm Reduction as Well as Abstinence; Kampo-Assisted Benzodiazepine Reduction Was Reported in Two Uncontrolled Cases.